The long road to zero

A Bangkok symposium on HIV/Aids looks at the progress being made to turn the disease from “epidemic” to “endemic”

Like most member nations of the United Nations, Thailand has set itself the goal of eliminating new infections of HIV/Aids and reaching “Getting to Zero” by 2030.

It is an ambition that faces many challenges. Current figures show that the nation has more than 400,000 HIV-infected patients and that 21 per cent of them are over the age of 50. Improved medical treatment and more efficient drugs will push an increasing number of those infected into the 50 years-plus bracket as the target date draws near, thus exposing them to age-related medical conditions.

At the same time, a the national survey in 2016, conducted by the Thai Red Cross Aids Research Centre in 2016 found 6,200 new patients being infected with HIV per year – or 17 persons per day – and that the majority of these were among the younger generation, especially men who have sex with men (MSM).

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below